呼吸衰竭是MAPT相关疾病的主要表现标志
Maud Favier1, Maité Formaglio2,3, Anne Cosson4
1Centre de Génétique Humaine, Centre Hospitalier Universitaire de Besançon, Besançon, France. maud.favier@aphp.fr.
Journal of neurology
|January 17, 2025
概括
这项研究确定了一种新的MAPT基因变异,导致一种严重的神经退行性疾病,其特征是早期呼吸衰竭. 这些发现扩大了已知的陶氏病的范围,突出了陶氏蛋白在神经功能和生存中的关键作用.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- MAPT基因编码了tau蛋白,这对神经元功能,微管稳定性和轴突运输至关重要.
- 致病性MAPT变异会导致自体主导性图帕病,这是神经退行性疾病的一组.
- 陶氏症的特征是异常的陶氏含有导致神经元损失和中枢神经系统退化.
研究的目的:
- 报告两个与MAPT相关的神经退行性疾病的无关家庭.
- 描述这种新型病的临床和遗传特征.
- 扩大对与MAPT变异相关的表型谱的理解.
主要方法:
- 来自两个家庭的9名受影响个体的临床评估.
- 基因分析包括基因组和外体序列测序,以确定致病变体.
- 在一个病人身上进行了死后脑免疫组织化学分析.
主要成果:
- 在MAPT基因中发现了一种新型异合体误解变异 (c.2041C>T,p.Pro681Ser).
- 受影响的个体呈现出快速进展的呼吸衰竭,包括呼吸不全,骨质疏松和呼吸不补偿.
- 神经学症状包括步态障碍,腹筋功能障碍,认知缺陷,在一个案例中,腹膜.
- 组织病理学揭示了不寻常的复合神经元tau含有,神经元损失和化.
结论:
- 鉴定到的MAPT变体与一种独特的神经退行性疾病有关,该疾病具有突出的呼吸衰竭.
- 这一观察扩大了MAPT相关疾病的表型谱.
- 早期呼吸衰竭和过早死亡是这种病的关键特征.
相关概念视频
Acute Respiratory Failure-III
154
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
154
Acute Respiratory Failure-IV
125
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
125
Acute Respiratory Failure-II
169
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
169
Acute Respiratory Failure-I
163
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
163
Acute Respiratory Failure-V
123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
168
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
168


